Commercializing breakthrough technology for Parkinson's disease, to streamline a communication path in the brain, reduce symptoms and restore independence.
Resonate Forward (RF) will launch two products, VibeForward and RMband, by Q3 2022. VibeForward reduces freezing and falling, so that patients walk independently. RMBand improves tremor, enabling self-care. With early clinical results, Michael J. Fox Foundation recognized the potential in this technology and funded a clinical program with VCU to demonstrate clinical results needed for FDA submission and commercialization.